Latest news
Stifel Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $10 - MoomooMoomoo · Sat, 08 Aug 2026 03:59:33 GMTProfound Medical Q2 Earnings Call Highlights - MarketBeatMarketBeat · Fri, 07 Aug 2026 09:29:32 GMTProfound Medical Corp (PROF) (Q2 2026) Earnings Call Highlights: Record Orders and ... - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 05:09:00 GMTProfound Medical (NASDAQ:PROF) Announces Earnings Results - MarketBeatMarketBeat · Fri, 07 Aug 2026 03:46:53 GMTProfound Medical (PROF) Q2 Earnings Surpass Estimates - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 02:35:00 GMTCanada's Profound Medical Q2 loss shrinks on lower costs, revenue hit by shipment timing - TradingViewTradingView · Thu, 06 Aug 2026 20:43:28 GMTProfound Medical (NASDAQ: PROF) boosts revenue 62% while cutting loss - Stock TitanStock Titan · Thu, 06 Aug 2026 20:33:31 GMTAbout $3.1M of Profound shipments will count as Q3 revenue - Stock TitanStock Titan · Thu, 06 Aug 2026 20:24:18 GMT